Hoff JT - Search Results

1

CD151 represses mammary gland development by maintaining the niches of progenitor cells.

Yin Y, Deng X, Liu Z, Baldwin LA, Lefringhouse J, Zhang J, Hoff JT, Erfani SF, Rucker EB 3rd, O'Connor K, Liu C, Wu Y, Zhou BP, Yang XH. Yin Y, et al. Among authors: hoff jt. Cell Cycle. 2014;13(17):2707-22. doi: 10.4161/15384101.2015.945823. Cell Cycle. 2014. PMID: 25486358 Free PMC article.

2

Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.

Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang XH. Deng X, et al. Neoplasia. 2012 Aug;14(8):678-89. doi: 10.1593/neo.12922. Neoplasia. 2012. PMID: 22952421 Free PMC article.

3

CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.

Baldwin LA, Hoff JT, Lefringhouse J, Zhang M, Jia C, Liu Z, Erfani S, Jin H, Xu M, She QB, van Nagell JR, Wang C, Chen L, Plattner R, Kaetzel DM, Luo J, Lu M, West D, Liu C, Ueland FR, Drapkin R, Zhou BP, Yang XH. Baldwin LA, et al. Among authors: hoff jt. Oncotarget. 2014 Dec 15;5(23):12203-17. doi: 10.18632/oncotarget.2622. Oncotarget. 2014. PMID: 25356755 Free PMC article.

4

Renal disease appears not to affect carcinogenesis in CD151-null mice.

Hemler ME, Hoff J, Li Q, Yang XH. Hemler ME, et al. Oncogene. 2013 Sep 12;32(37):4458. doi: 10.1038/onc.2013.79. Epub 2013 Mar 18. Oncogene. 2013. PMID: 23503459 No abstract available.

5

Survival Advantage Associated with Decrease in Stage at Detection from Stage IIIC to Stage IIIA Epithelial Ovarian Cancer.

Hoff J, Baldwin L, Lefringhouse J, Pavlik E, Miller R, DeSimone C, Ueland F, Tucker T, Kryscio R, van Nagell JR. Hoff J, et al. J Oncol. 2014;2014:312193. doi: 10.1155/2014/312193. Epub 2014 Sep 1. J Oncol. 2014. PMID: 25254047 Free PMC article.

6

Metrics of the gynecologic oncology literature focused on cited utilization and costs.

Pavlik EJ, Hoff J, Woolum D, Liang Y, Wijers C, Schwartz M, Lefringhouse J, Baldwin L. Pavlik EJ, et al. Gynecol Oncol. 2014 Feb;132(2):423-7. doi: 10.1016/j.ygyno.2013.12.008. Epub 2013 Dec 13. Gynecol Oncol. 2014. PMID: 24333363

7

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.

Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR Jr. Pavlik EJ, et al. Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-217. doi: 10.1097/AOG.0b013e318298def5. Obstet Gynecol. 2013. PMID: 23969786

8

Transvaginal ultrasonography in ovarian cancer screening: current perspectives.

van Nagell JR Jr, Hoff JT. van Nagell JR Jr, et al. Among authors: hoff jt. Int J Womens Health. 2013 Dec 20;6:25-33. doi: 10.2147/IJWH.S38347. Int J Womens Health. 2013. PMID: 24379701 Free PMC article. Review.

9

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.

Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR Jr, Ueland FR. Elder JW, et al. Among authors: hoff jt. Gynecol Oncol. 2014 Oct;135(1):8-12. doi: 10.1016/j.ygyno.2014.07.091. Epub 2014 Jul 25. Gynecol Oncol. 2014. PMID: 25068975

10

Wound complications after gynecologic cancer surgery.

Nugent EK, Hoff JT, Gao F, Massad LS, Case A, Zighelboim I, Mutch DG, Thaker PH. Nugent EK, et al. Among authors: hoff jt. Gynecol Oncol. 2011 May 1;121(2):347-52. doi: 10.1016/j.ygyno.2011.01.026. Epub 2011 Feb 15. Gynecol Oncol. 2011. PMID: 21324517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page